Sales 20% and EBIT adj. 34% vs. ABGSCe Strong quarter with record turnover Set to enter next phase o...
Redeye provides an update following WntResearch’s Q2 report.
Redeye updates on Better Collective following its Q2-results which were in line with our expectation...
First Venture publicerade den 22 augusti 2024 bolagets delårsrapport för det andra kvartalet av 2024...
We lower '24e revenue by 21%, but lift '26e by 18% 2nd IPU design win secured, pipeline continues to...
Redeye comments on Medivir's Q2 report. The main event in the quarter was the presentation of an est...
Redeye updates its estimates following Surgical Science’s Q2 2024 report, which featured a sequentia...
Redeye has made only minor revisions to its forecast following Modelon’s Q2 report, in which the rep...
Arctic Blue Beverages AB (”Arctic Blue Beverages” eller ”Bolaget”) redovisar en minskad nettoomsättn...
Updating estimates after full release of H1 numbers More guidance upgrades possible + M&A increasing...
ExpreS2ion Biotech har tagit ett steg närmare att inleda en first-in-human studie med sitt bröstcanc...
Redeye comments on Enviro’s Q2 report, which held no surprises.
Net sales were 9% lower than our estimate. Costs were in line with our expectations, which led to lo...
Idag publicerade Fable Media sin delårsrapport för kv2 2024.
Revenues and EBIT 2 and 14% ahead of expectations Order intake of DKK 2.
